Author

Steve Lianoglou

Denali Therapeutics (United States)ORCID 0000-0002-0924-1754Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Anil C. Nair· 1 shared Bin Cao· 1 shared Charles K. AbramsiD· 1 shared Chia-Ching John LiniD· 1 shared Connie HaiD· 1 shared Dan Xia· 1 shared David Gong· 1 shared Dylan T. Garceau· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Anil C. Nair

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintAug 6, 2026

Pharmacologic eIF2B Activation Rescues Neuropathy in CMT2 Subtypes by Normalizing the Integrated Stress Response

Mary E. McMahon, Steve Lianoglou, Sridhar Narayan…·Paul R. August

RTX-117, a clinical stage eIF2B activator, blunts chronic ISR activation and improves nerve and motor function in a mouse model of Charcot-Marie-Tooth Disease Type 2D.

DOI 10.64898/2026.08.05.743063

mouseproteomics

𝕏 PostBluesky

NeurosciencebioRxivPreprintJan 19, 2021

Fibrillar Aβ causes profound microglial metabolic perturbations in a novel APP knock-in mouse model

Dan Xia, Steve Lianoglou, Thomas Sandmann…·Pascal E. Sanchez

This paper characterizes microglial metabolic changes in an APP knock-in mouse model of AD, finding lipid dysregulation and immunometabolic perturbations linked to fibrillar Aβ.

5 citations

mouseexperimental assay

𝕏 PostBluesky